ACT BIOTECH
ACT Biotech is uniquely positioned to bring innovative therapies to bear in managing cancer, especially in underserved disease sectors where patient need is acute. The Company's advantages include a seasoned, international leadership team, unmatched expertise in clinical development and commercialization, and an exceptional portfolio of pre-clinical drug candidates. ACT has launched an aggressive, focused development strategy designed to accelerate delivery of therapeutic tools to respond to the needs of cancer patients. The Company's strength and stability provide unique opportunities for corporate partnerships to help advance its portfolio of promising, validated drug compounds.
ACT BIOTECH
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.actbiotech.com
Total Employee:
11+
Status:
Active
Contact:
212-972-0077
Email Addresses:
[email protected]
Total Funding:
25.98 M USD
Technology used in webpage:
SPF Google Font API Google Analytics Amazon Nginx Amazon Virginia Region CloudFront Google Analytics Classic Google Adsense Google Adsense For Domains
Similar Organizations
Adartis Animal Health
Adartis Animal Health is a US registered Bio-Pharmaceutical firm focused on the licensing, registration, and marketing.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Cyclicor
Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers.
Pax Neuroscience
Pax Neuroscience is a life sciences company focused on the global development and commercialization of protein biomarker.
Peninsula Pharmaceuticals
A biopharmaceutical company focused on the development and commercialization of antibiotics.
PregLem
PregLem is a Swiss based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for
Ruthigen
They are a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous
Spannerwerks
Spannerwerks offers a consortium of experts covering all areas of drug and biologic development and commercialization.
TCD Pharma
TCD Pharma is a biotechnology company engaged in the discovery, development and commercialization of oncology drugs.
Current Advisors List
Current Employees Featured
Investors List
NGN Capital
NGN Capital investment in Series A - ACT Biotech
Official Site Inspections
http://www.actbiotech.com
- Host name: ec2-54-243-117-197.compute-1.amazonaws.com
- IP address: 54.243.117.197
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "ACT Biotech"
ACT Biotech Inc - Wikipedia
ACT Biotech Inc is a San Francisco-based, privately held biopharmaceutical company focused on the development and commercialization of targeted cancer drugs. [1] [2] It was founded in …See details»
ACT Biotech - Crunchbase Company Profile & Funding
ACT Biotech is a biopharmaceutical company focused on the development and commercialization of cancer drugs.See details»
ACT Biotech 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for ACT Biotech. Use the PitchBook Platform to explore the full profile.See details»
ACT Biotech Company Profile | Management and Employees List
ACT Biotech Profile and History . ACT Biotech, Inc., is a biopharmaceutical company that was founded in 2008. Prior to Eddingpharm's asset acquisition, ACT Biotech focused on the …See details»
ACT Biotech - Company Profile - Tracxn
Feb 26, 2025 ACT Biotech, is a biopharmaceutical company that develops oral small molecule kinase inhibitors as anti-cancer drugs. Its products include drugs with mechanisms of action in …See details»
ACT Biotech - Products, Competitors, Financials, Employees ...
May 28, 2014 Headquarters Location. 717 Market Street Suite 650. San Francisco, California, 94103, United States. 415-230-3900See details»
ACT Biotech Inc - Company Profile and News - Bloomberg Markets
Company profile page for ACT Biotech Inc including stock price, company news, executives, board members, and contact informationSee details»
ACT Biotech - Contacts, Employees, Board Members, Advisors
ACT Biotech is a biopharmaceutical company focused on the development and commercialization of cancer drugs.See details»
ACT Biotech Inc - LinkedIn
ACT Biotech Inc | 56 followers on LinkedIn. ... Fusion Foods and Catering Private Ltd. Food and Beverage ManufacturingSee details»
ACT Biotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ACT Biotech, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, and 2 literature, Drug:EDP-317, ACTB-1011, Telatinib.See details»
ACT Biotech - EquityNet
ACT Biotech is uniquely positioned to bring innovative therapies to bear in managing cancer, especially in underserved disease sectors where patient need is acute. The Companys …See details»
ACT Biotech CEO, Founder, Key Executive Team, Board of Directors ...
Explore {ACT Biotech's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
ACT Biotech (Molecule Drug Assets) - PitchBook
Feb 19, 2014 Information on acquisition, funding, cap tables, investors, and executives for ACT Biotech (Molecule Drug Assets). Use the PitchBook Platform to explore the full profile.See details»
ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio ...
May 8, 2008 NGN Capital announced the formation of ACT Biotech Inc., a new company dedicated to developing and commercializing targeted oral cancer drugs.ACT Biotech has …See details»
Advanced Proteome Therapeutics - Crunchbase Company Profile …
Contact Email [email protected] Phone Number (617)638-0340 Cancer is a complex disease, and for therapies to be maximally effective, they must distinguish between normal …See details»
中科新生命 - aptbiotech.com
愿景——成为质谱多组学和数据驱动型生命科学技术服务领导者. 以技术创新、产品创新、服务创新、理念创新作为核心竞争力，将中科新生命缔造成为生命科学领域具有全球影响力的实力品 …See details»
Alberta Cell Therapy Manufacturing – Enabling the future of …
May 18, 2021 Regenerative medicine and cell therapies are the future of medicine. They offer the potential to transform the treatment of disease such as cancer and diabetes and the ability …See details»
Landmark Bio Acquired by Artis BioSolutions to Expand …
2 days ago The organization was established by leaders from academia, industry, and Boston's leading research hospitals. Together with Artis BioSolutions, Landmark Bio will enhance its …See details»
“单”愿有你 | 单细胞蛋白质组学重磅来袭 - aptbiotech.com
Dec 27, 2021 编者按在刚刚过去的2021年度蛋白质组学领域最高规格的学术大会——HUPO国际大会（Human Proteome Organization World Congress）上，单细胞受到了极大的关注，其 …See details»
APTBIO - Crunchbase Company Profile & Funding
APTBIO is a proteomic technology firm. APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the …See details»